Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm

Bioinformatics

Volumn 32, Issue 17, 2016, Pages 2664-2671

  Luo, Huimin ^a,b   Wang, Jianxin ^a   Li, Min ^a   Luo, Junwei ^a   Peng, Xiaoqing ^a   Wu, Fang Xiang ^c   Pan, Yi ^d  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b HENAN UNIVERSITY   (China)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

^d GEORGIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; BIOLOGY; DRUG REPOSITIONING; PROCEDURES; THEORETICAL MODEL;

ALGORITHMS; COMPUTATIONAL BIOLOGY; DRUG REPOSITIONING; MODELS, THEORETICAL;

EID: 84990913647     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btw228     Document Type: Conference Paper

References (32)

1. Ashburn, T.T. et al. (2004) Drug repositioning: identifying and developing new uses for existing drugs. Nat. Rev. Drug Discov., 3, 673-683
2. Cavestro, C. et al. (2006) High prolactin levels as a worsening factor for migraine. J. Headache Pain, 7, 83-89
3. Chen, X. et al. (2012) Drug-target interaction prediction by random walk on the heterogeneous network. Mol. BioSyst., 8, 1970-1978
4. Chen, H. et al. (2015) Network-based inference methods for drug repositioning. Comput. Math. Methods Med., 2015, 130620
5. Cheng, F. et al. (2012) Prediction of drug-target interactions and drug repositioning via network-based inference. PLoS Comput. Biol., 8, e1002503
6. Chiang, A.P. and Butte, A.J. (2009) Systematic evaluation of drug-disease relationships to identify leads for novel drug uses. Clin. Pharmacol. Therap., 86, 507-510
7. ClinicalTrials.gov (2006a) Docetaxel, Doxorubicin, and Prednisone in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy
8. ClinicalTrials.gov (2006b) Dopaminergic enhancement of learning and memory in healthy adults and patients with dementia/mild cognitive impairment
9. Davis, A.P. et al. (2015) The Comparative Toxicogenomics Database's 10th year anniversary: update 2015. Nucleic Acids Res., 43, D914-D920
10. Erkulwater, S. and Pillai, R. (1989) Amantadine and the end-stage dementia of Alzheimerś type. Southern Med. J., 82, 550-554
11. Fisher, R.A. and Yates, F. (1938) Statistical tables for biological, agricultural and medical research. Edinburgh: Oliver and Boyd
12. Hamosh, A. et al. (2002) Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res., 30, 52-55
13. Hurle, M.R. et al. (2013) Computational drug repositioning: from data to therapeutics. Clin. Pharmacol. Therap., 93, 335-341
14. Gottlieb, A. et al. (2011) PREDICT: a method for inferring novel drug indications with application to personalized medicine. Mol. Syst. Biol., 77, 496
15. Grabowski, H. (2004) Are the economics of pharmaceutical research and development changing? Pharmacoeconomics, 22, 15-24
16. Kanehisa, M. et al. (2014) Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res., 42, D199-D205
17. Li, J. et al. (2015) A survey of current trends in computational drug repositioning. Brief. Bioinf., 1, 11
18. Lipscomb, C.E. (2000) Medical subject headings (MeSH). Bull. Med. Libr. Assoc., 88, 265-266
19. Martínez, V. et al. (2015) DrugNet: Network-based drug-disease prioritization by integrating heterogeneous data. Artif. Intell. Med., 63, 41-49
20. Nepusz, T. et al. (2012) Detecting overlapping protein complexes in protein-protein interaction networks. Nat. Methods, 9, 471-472
21. Shim, J.S. and Liu, J.O. (2014) Recent advances in drug repositioning for the discovery of new anticancer drugs. Int. J. Biol. Sci., 10, 654
22. Steinbeck, C. et al. (2006) Recent developments of the chemistry development kit(CDK)-an open-source java library for chemo-and bioinformatics. Curr. Pharm. Des., 12, 2111-2120
23. Tanimoto, T. (1957) An Elementary Mathematical theory of Classification and Prediction. Internal IBM Technical Report
24. Wang, W. et al. (2013) Drug target predictions based on heterogeneous graph inference. Pac. Symp. Biocomput, 18, 53-64
25. Wang, W. et al. (2014) Drug repositioning by integrating target information through a heterogeneous network model. Bioinformatics, 30, 2923-2930
26. Weininger, D. (1988) SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. J. Chem. Inf. Model., 28, 31-36
27. Wishart, D.S. et al. (2008) DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res., 36, D901-D906
28. Wu, C. et al. (2013) Computational drug repositioning through heterogeneous network clustering. BMC Syst. Biol., 7, S6
29. Van Driel, M.A. et al. (2006) A text-mining analysis of the human phenome. Eur. J. Human Genet., 14, 535-542
30. Vanunu, O. et al. (2010) Associating genes and protein complexes with disease via network propagation. PLoS Comput. Biol., 6, e1000641
31. Xie, M. et al. (2012) Prioritizing disease genes by bi-random walk. Adv. Knowl. Discov. Data Mining, 2, LNCS, 7302, 292-303
32. Yu, L. et al. (2015) Inferring drug-disease associations based on known protein complexes. BMC Med. Genomics, 8, S2